Baird Maintains Neutral on Hinge Health, Raises Price Target to $90
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises the price target from $85 to $90.
Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises the price target from $85 to $90.